This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A forum of leading clinical development
and medical experts stewarding advances
in science and clinical research for the
continuum of metabolic diseases
Events
8th Metabolic Continuum Roundtable™ Annual Meeting – More details coming soon
Contact Us »
7th Metabolic Continuum Roundtable™ Annual Meeting – Steatotic Liver Disease (MASLD/MASH): Disease Burden – Patient Reported Outcomes – Health Economics: Payor & Societal Perspectives
November 10, 2023 | Boston, MA
More Information »
6th NASH Roundtable™ Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?
November 5, 2022 | Washington, DC
More information »
5th NASH Roundtable™ Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?
June 16, 2022 | Virtual
More information »
Resources
Fact Sheet: Metabolic Continuum Roundtable™, leading clinical development experts addressing challenges in NASH drug development
Member Co-authored Publications
March 5, 2025
MASLD as a non-communicable disease. Read More »
Feburary 20, 2025
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis. Read More »
February 18, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors’ Perspective. Read More »
February 15, 2025
Non-invasive evaluation of steatosis and fibrosis in the liver in adult patients living with cystic fibrosis. Read More »
February 11, 2025
The Lipidomic Profile Discriminates Between MASLD and MetALD. Read More »